Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 02-2017 | 11-2016 | 08-2016 | 05-2016 | 02-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,213 | 4,719 | 3,345 | N/A | -16,251 |
| Depreciation Amortization | 7,827 | 5,110 | 2,550 | N/A | 6,486 |
| Income taxes - deferred | 3,437 | 2,317 | 1,727 | N/A | -10,560 |
| Accounts receivable | 488 | -3,603 | 2,256 | N/A | 3,555 |
| Accounts payable and accrued liabilities | -6,140 | -4,990 | 709 | N/A | -9,918 |
| Other Working Capital | 65 | -9,682 | -1,958 | N/A | -8,806 |
| Other Operating Activity | 9,291 | 11,656 | -2,162 | 0 | 41,924 |
| Operating Cash Flow | $23,181 | $5,527 | $6,467 | $N/A | $6,430 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,414 | -4,724 | -2,122 | N/A | -26,032 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -850 |
| Investing Cash Flow | $-9,414 | $-4,724 | $-2,122 | $N/A | $-26,882 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,500 | 1,500 | N/A | N/A | 19,500 |
| Debt Issued | 50,000 | 50,000 | N/A | N/A | 26,748 |
| Debt Repayment | -55,966 | -54,697 | -1,909 | N/A | -12,150 |
| Common Stock Issued | 233 | 193 | 98 | N/A | 282 |
| Other Financing Activity | -6,694 | -5,127 | -3,802 | 0 | -19,841 |
| Financing Cash Flow | $-10,927 | $-8,131 | $-5,613 | $N/A | $14,539 |
| Beginning Cash Position | 9,894 | 9,894 | 9,894 | N/A | 14,127 |
| End Cash Position | 12,734 | 2,566 | 8,626 | N/A | 8,214 |
| Net Cash Flow | $2,840 | $-7,328 | $-1,268 | $N/A | $-5,913 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,181 | 5,527 | 6,467 | N/A | 6,430 |
| Capital Expenditure | -9,488 | -4,738 | -2,131 | N/A | -26,159 |
| Free Cash Flow | 13,693 | 789 | 4,336 | 0 | -19,729 |